PKCε is overexpressed in many types of cancer, including bladder cancer [14], prostate cancer [15], breast cancer [16], head and neck squamous cell carcinoma [17], and lung cancer [18] as well as RCC cell lines [19,20]. Here, PRKCE is linked to renal cell adenocarcinoma.